Zadie Davis Selected Research

Cyclophosphamide (Cytoxan)

11/2023	Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY.
12/2012	Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zadie Davis Research Topics

Disease

17	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2024 - 02/2002
3	Neoplasms (Cancer) 11/2023 - 10/2009
3	Lymphoma (Lymphomas) 01/2019 - 11/2015
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2019 - 08/2007
3	Disease Progression 10/2016 - 06/2003
1	Melanoma (Melanoma, Malignant) 11/2023
1	Prostatic Neoplasms (Prostate Cancer) 11/2023
1	Leukemia 12/2012
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2009
1	Lymphocytosis 08/2007

Drug/Important Bio-Agent (IBA)

13	Immunoglobulins (Immunoglobulin)IBA 02/2024 - 08/2007
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 12/2012
2	fludarabineIBA 11/2023 - 12/2012
2	AntigensIBA 01/2019 - 04/2016
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 06/2003 - 06/2003
1	Rituximab (Mabthera)FDA Link 11/2023
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2019
1	ChromatinIBA 01/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2015
1	Chlorambucil (Leukeran)FDA Link 12/2012
1	Hemoglobins (Hemoglobin)IBA 09/2010
1	MicroRNAs (MicroRNA)IBA 10/2009
1	Immunoglobulin Variable RegionIBA 02/2002

Therapy/Procedure

2	Therapeutics 01/2018 - 05/2012